Patents Assigned to Michael Stroehlein
  • INITIAL RELATIVE LYMPHOCYTE COUNT AS PREDICTIVE BIOMARKER
    Publication number: 20150037278
    Abstract: The invention relates to a method for predicting an improved therapeutic benefit for an individual with a tumor load before initiating an immune therapy which is capable of activating immune cells against said tumor as well as to pharmaceutical compositions for use in this method.
    Type: Application
    Filed: May 16, 2012
    Publication date: February 5, 2015
    Applicants: Michael Stroehlein, Markus Heiss
    Inventors: Horst Lindhofer, Markus Heis, Michael Stroehlein